213 related articles for article (PubMed ID: 9923924)
1. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract][Full Text] [Related]
2. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
3. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
Fanburg JC; Rosenberg AE; Weaver DL; Leslie KO; Mann KG; Taatjes DJ; Tracy RP
Am J Clin Pathol; 1997 Oct; 108(4):464-73. PubMed ID: 9322601
[TBL] [Abstract][Full Text] [Related]
4. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
6. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
9. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
10. Malignant fibrous histiocytoma of bone and osteosarcoma. A comparative light and electron microscopic study.
Roessner A; Hobik HP; Grundmann E
Pathol Res Pract; 1979 Aug; 164(4):385-401. PubMed ID: 229475
[TBL] [Abstract][Full Text] [Related]
11. Primary giant-cell-rich osteosarcoma of the urinary bladder: usefulness of osteocalcin and osteonectin immunohistochemical staining and literature review.
Won KY; Lee CH; Kim YW; Park YK
Pathology; 2011 Feb; 43(2):161-4. PubMed ID: 21233679
[No Abstract] [Full Text] [Related]
12. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
Moosavi C; Jha P; Fanburg-Smith JC
Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
[TBL] [Abstract][Full Text] [Related]
13. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors.
O'Connell JX; Wehrli BM; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2000 Mar; 24(3):386-95. PubMed ID: 10716152
[TBL] [Abstract][Full Text] [Related]
14. [Bone matrix production in osteosarcoma].
Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expressions of c-fos and c-jun products and bone matrix proteins: a clinicopathologic review and immunohistochemical study of c-fos, c-jun, type I collagen, osteonectin, osteopontin, and osteocalcin.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 1999 Dec; 30(12):1418-26. PubMed ID: 10667418
[TBL] [Abstract][Full Text] [Related]
16. Osteocalcin expression in primary bone tumors--in situ hybridization and immunohistochemical study.
Park YK; Yang MH; Kim YW; Park HR
J Korean Med Sci; 1995 Aug; 10(4):263-8. PubMed ID: 8593206
[TBL] [Abstract][Full Text] [Related]
17. Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
Bosse A; Ueda Y; Wuisman P; Jones DB; Vollmer E; Roessner A
J Cancer Res Clin Oncol; 1991; 117(1):43-9. PubMed ID: 1997469
[TBL] [Abstract][Full Text] [Related]
18. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
19. Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases.
Lidang Jensen M; Schumacher B; Myhre Jensen O; Steen Nielsen O; Keller J
Am J Surg Pathol; 1998 May; 22(5):588-94. PubMed ID: 9591729
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases.
Bane BL; Evans HL; Ro JY; Carrasco CH; Grignon DJ; Benjamin RS; Ayala AG
Cancer; 1990 Jun; 65(12):2762-70. PubMed ID: 2160317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]